Verve Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corporation |
$6.30 | $532.00 M | -2.42 | 709 | $170.28 M |
BEAM
Beam Therapeutics Inc. |
$26.58 | $1.91 B | -14.51 | 472 | $377.71 M |
BPMC
Blueprint Medicines Corporation |
$89.36 | $6.47 B | -21.48 | 638 | $249.38 M |
CRBU
Caribou Biosciences, Inc. |
$1.66 | $176.12 M | -1.41 | 158 | $34.48 M |
CRSP
CRISPR Therapeutics AG |
$40.02 | $4.91 B | -21.43 | 407 | $371.21 M |
EDIT
Editas Medicine, Inc. |
$1.22 | $435.86 M | -2.56 | 265 | $78.12 M |
IPSC
Century Therapeutics, Inc. |
$1.04 | $244.54 M | -1.32 | 152 | $2.24 M |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
NTLA
Intellia Therapeutics, Inc. |
$11.98 | $2.19 B | -4.23 | 526 | $36.28 M |
PRME
Prime Medicine, Inc. |
$2.91 | $788.60 M | -3.01 | 234 | $0 |
RLAY
Relay Therapeutics, Inc. |
$4.37 | $1.05 B | -3 | 294 | $25.55 M |
SANA
Sana Biotechnology, Inc. |
$1.61 | $1.55 B | -4.59 | 328 | $0 |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |